​

Leap Therapeutics Ownership | Who Owns Leap Therapeutics?

OverviewForecastRevenueFinancialsChart

Leap Therapeutics Ownership Summary

Leap Therapeutics is owned by 11.09% institutional investors, 11.91% insiders, and 77.00% retail investors. Vanguard group is the largest institutional shareholder, holding 5.13% of LPTX shares. Simplify Health Care ETF is the top mutual fund, with 2.02% of its assets in Leap Therapeutics shares.

LPTX Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockLeap Therapeutics11.09%11.91%77.00%
SectorHealthcare Stocks 50.44%12.38%37.18%
IndustryBiotech Stocks 48.97%12.07%38.96%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Vanguard group2.13M5.13%$2.47M
Blackrock funding, inc. /de2.34M3.54%$1.86M
Geode capital management571.07K0.86%$453.92K
Vanguard fiduciary trust297.09K0.45%$236.18K
Susquehanna group, llp262.95K0.40%$208.94K
Ubs group171.07K0.26%$136.00K
Lpl financial162.49K0.25%$129.12K
Two sigma advisers, lp99.68K0.24%$45.26K
State street140.11K0.21%$111.33K
Group one trading107.42K0.16%$85.35K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Key client fiduciary advisors80.42K0.02%$63.91K
Texas capital bank wealth management services104.20K0.00%$82.80K
Quadrant private wealth management11.20K0.00%$8.90K
Adar1 capital management25.83K0.00%$11.73K
Gerber kawasaki wealth & investment management22.00K0.00%$17.48K
Keystone financial group11.71K0.00%$9.31K
Xtx topco30.66K0.00%$24.36K
Virtu financial10.19K0.00%$8.00K
Simplify asset management21.14K0.00%$16.80K
Iht wealth management11.00K0.00%$8.74K

Top Buyers

HolderShares% AssetsChange
Vanguard group2.13M-966.43K
Vanguard fiduciary trust297.09K0.00%297.09K
Ubs group171.07K-139.92K
Lpl financial162.49K-129.73K
Two sigma advisers, lp99.68K0.00%58.40K

Top Sellers

HolderShares% AssetsChange
Gilead sciences---5.32M
Samsara biocapital---2.44M
Simplify asset management21.14K0.00%-1.85M
683 capital management---1.44M
Point72 asset management---1.40M

New Positions

HolderShares% AssetsChangeValue
Vanguard fiduciary trust297.09K0.00%297.09K$236.18K
Gerber kawasaki wealth & investment management22.00K0.00%22.00K$17.48K
Vanguard global advisers11.61K-11.61K$9.23K
Quadrant private wealth management11.20K0.00%11.20K$8.90K
Virtu financial10.19K0.00%10.19K$8.00K

Sold Out

HolderChange
Caldwell sutter capital-4.00
Financial management professionals-20.00
Newedge advisors-82.00
Fortitude family office-182.00
Federation des caisses desjardins du quebec-500.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 2026466.98%7,334,272-15.00%112.56%20-25.93%6-14.29%
Dec 31, 202526-25.71%7,722,557-39.13%181.99%16100.00%5-37.50%
Sep 30, 202524-44.19%11,035,559-19.80%262.40%6-62.50%4-60.00%
Jun 30, 202543-8.51%13,760,432-17.57%332.04%16-15.79%10-33.33%
Mar 31, 202547-21.67%16,693,179-13.67%401.53%19-44.12%1587.50%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Simplify Health Care ETF837.65K2.02%-19.71K
Vanguard US Total Market Shares ETF754.74K1.83%-
Vanguard Total Stock Mkt Idx Inv738.59K1.78%-16.14K
Vanguard Institutional Extnd Mkt Idx Tr270.89K0.65%-123.44K
BIT Biotech Opportunities S192.30K0.47%-
Fidelity Extended Market Index168.34K0.41%-1.19K
BlackRock Extended Equity Market K82.86K0.22%-35.00
BIT Global Leaders I - I81.00K0.20%-
Extended Equity Market Fund K80.38K0.19%-1.60K
iShares Micro-Cap ETF61.84K0.15%-

Recent Insider Transactions

DateNameRoleActivityValue
Sep 24, 2021BeiGene, Ltd.-Buy$7.25M

Insider Transactions Trends

DateBuySell
2025 Q2--
2025 Q1--
2024 Q4--
2024 Q2--
2024 Q1--

LPTX Ownership FAQ

Who Owns Leap Therapeutics?

Leap Therapeutics shareholders are primarily institutional investors at 11.09%, followed by 11.91% insiders and 77.00% retail investors. The average institutional ownership in Leap Therapeutics's industry, Biotech Stocks , is 48.97%, which Leap Therapeutics falls below.

Who owns the most shares of Leap Therapeutics?

Leap Therapeutics’s largest shareholders are Vanguard group (2.13M shares, 5.13%), Blackrock funding, inc. /de (2.34M shares, 3.54%), and Geode capital management (571.07K shares, 0.86%). Together, they hold 9.54% of Leap Therapeutics’s total shares outstanding.

Does Blackrock own Leap Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Leap Therapeutics.

Who is Leap Therapeutics’s biggest shareholder by percentage of total assets invested?

Key client fiduciary advisors is Leap Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.02% of its assets in 80.42K Leap Therapeutics shares, valued at 63.9K$.

Who is the top mutual fund holder of Leap Therapeutics shares?

Simplify Health Care ETF is the top mutual fund holder of Leap Therapeutics shares, with 2.02% of its total shares outstanding invested in 837.65K Leap Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools